Stefan Weiler
Stefan Weiler
Potvrđena adresa e-pošte na
Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion
H Vogelsinger, S Weiler, A Djanani, J Kountchev, R Bellmann-Weiler, ...
Journal of Antimicrobial chemotherapy 57 (6), 1153-1160, 2006
Liver allograft failure after nivolumab treatment—a case report with systematic literature research
D Gassmann, S Weiler, JC Mertens, CS Reiner, B Vrugt, M Nägeli, ...
Transplantation direct 4 (8), 2018
Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis
TH Collet, DC Bauer, AR Cappola, BO Åsvold, S Weiler, E Vittinghoff, ...
The journal of clinical endocrinology & metabolism 99 (9), 3353-3362, 2014
Disease-specific sparing of the anterior semicircular canals in bilateral vestibulopathy
AA Tarnutzer, CJ Bockisch, E Buffone, S Weiler, LM Bachmann, ...
Clinical Neurophysiology 127 (8), 2791-2801, 2016
Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy
S Weiler, C Seger, H Pfisterer, E Stienecke, F Stippler, R Welte, ...
Antimicrobial agents and chemotherapy 57 (8), 4053-4057, 2013
Drug-induced liver injury: the dawn of biomarkers?
S Weiler, M Merz, GA Kullak-Ublick
F1000prime reports 7, 2015
Altered pharmacokinetics of voriconazole in a patient with liver cirrhosis
S Weiler, H Zoller, I Graziadei, W Vogel, R Bellmann-Weiler, M Joannidis, ...
Antimicrobial agents and chemotherapy 51 (9), 3459, 2007
Human tissue distribution of voriconazole
S Weiler, D Fiegl, R MacFarland, E Stienecke, R Bellmann-Weiler, ...
Antimicrobial agents and chemotherapy 55 (2), 925-928, 2011
Thromboembolic safety reporting of tofacitinib and baricitinib: an analysis of the WHO VigiBase
E Vallejo-Yagüe, S Weiler, R Micheroli, AM Burden
Drug Safety 43, 881-891, 2020
Clinical Course, Radiological Manifestations, and Outcome of Pneumocystis jirovecii Pneumonia in HIV Patients and Renal Transplant Recipients
L Ebner, LN Walti, A Rauch, H Furrer, A Cusini, AMJ Meyer, S Weiler, ...
PLoS One 11 (11), e0164320, 2016
Clinical manifestations, pathophysiology, treatment and outcome of inflammatory bowel diseases in older people
M Butter, S Weiler, L Biedermann, M Scharl, G Rogler, HA Bischoff-Ferrari, ...
Maturitas 110, 71-78, 2018
Teicoplanin pharmacokinetics in critically ill patients On Continuous veno-venous
R Bellmann, G Falkensammer, C Seger, S Weiler, J Kountchev
International journal of clinical pharmacology and therapeutics 48 (4), 243-249, 2010
Penetration of amphotericin B lipid formulations into pleural effusion
S Weiler, R Bellmann-Weiler, M Joannidis, R Bellmann
Antimicrobial agents and chemotherapy 51 (11), 4211-4213, 2007
Multimorbidity and quality of preventive care in Swiss university primary care cohorts
S Streit, BR da Costa, DC Bauer, TH Collet, S Weiler, L Zimmerli, P Frey, ...
PloS one 9 (4), e96142, 2014
Cardiovascular safety profile of romosozumab: a pharmacovigilance analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)
A Vestergaard Kvist, J Faruque, E Vallejo-Yagüe, S Weiler, EM Winter, ...
Journal of Clinical Medicine 10 (8), 1660, 2021
Pulmonary epithelial lining fluid concentrations after use of systemic amphotericin B lipid formulations
S Weiler, G Falkensammer, A Hammerer-Lercher, M Anliker, ...
Antimicrobial agents and chemotherapy 53 (11), 4934-4937, 2009
Levels of amphotericin B lipid formulations in ascites
S Weiler, R Bellmann-Weiler, S Dunzendorfer, M Joannidis, R Bellmann
Journal of antimicrobial chemotherapy 62 (5), 1163-1164, 2008
Incidence of differentiation syndrome associated with treatment regimens in acute myeloid leukemia: a systematic review of the literature
L Gasparovic, S Weiler, L Higi, AM Burden
Journal of clinical medicine 9 (10), 3342, 2020
Cetuximab induced aseptic meningitis
A Ulrich, S Weiler, M Weller, T Rordorf, AA Tarnutzer
Journal of Clinical Neuroscience 22 (6), 1061-1063, 2015
Radiation recall dermatitis induced by sorafenib: A case study and review of the literature
S Stieb, O Riesterer, C Brüssow, BC Pestalozzi, M Guckenberger, ...
Strahlentherapie und Onkologie 195 (5), 342-348, 2016
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20